Skip to main content
Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
2.780
+0.200 (7.75%)
At close: Apr 25, 2025, 4:00 PM
2.780
0.00 (0.00%)
After-hours: Apr 25, 2025, 4:43 PM EDT

Orchestra BioMed Holdings Revenue

In the year 2024, Orchestra BioMed Holdings had annual revenue of $2.64M, down -4.42%. Orchestra BioMed Holdings had revenue of $253.00K in the quarter ending December 31, 2024, a decrease of -3.44%.

Revenue (ttm)
$2.64M
Revenue Growth
-4.42%
P/S Ratio
38.80
Revenue / Employee
$37,686
Employees
70
Market Cap
106.51M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20242.64M-122.00K-4.42%
Dec 31, 20232.76M-773.00K-21.88%
Dec 31, 20223.53M4.32M-551.79%
Dec 31, 2021-782.00K-6.49M-113.71%
Dec 31, 20205.70M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 410.06B
Johnson & Johnson 89.33B
Merck & Co. 63.92B
AbbVie 57.37B
AstraZeneca 54.07B
Novartis AG 51.72B
Eli Lilly and Company 45.04B
Thermo Fisher Scientific 42.90B
Revenue Rankings

OBIO News

More News